Gritstone bio ( NASDAQ: GRTS ) is scheduled to announce Q1 earnings results on Thursday, May 9th, after market close. The consensus EPS Estimate is -$0.31 and the consensus Revenue Estimate is $2.
85M (+16.8% Y/Y). Over the last 3 months, EPS estimates have seen 2 upward revisions and 0 downward.
Revenue estimates have seen 1 upward revision and 1 downward. More on Gritstone bio Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering Gritstone stock plunges 35% amid Phase 2 data, public offering Gritstone announces proposed public offering Seeking Alpha’s Quant Rating on Gritstone bio Historical earnings data for Gritstone bio.
